Articles > New & Newsworthy

Such a technique might one day help researchers devise treatments to cause dormant cells to begin to create insulin again. More research will be needed to validate this preliminary effort, however.

If approved, it could have the potential to reshape how severe hypoglycemia is treated.

There were new devices, new ideas, and lots of controversy.

Three individuals with type 1 diabetes were followed for eight years after they were injected with the BCG virus, but the effort is too small to draw any conclusions on the treatment.

  T1D Exchange reached out to Dr. Mark Atkinson and Carol Atkinson, who have been working around the clock to get insulin and supplies to people affected by the hurricanes. Carol Atkinson, Director at Insulin for Life USA, speaks with T1D Exchange’s Dr. Alicia McAuliffe-Fogarty about the current needs of Insulin for Life to help […]

Medtronic has become aware of recent reports of potential over-delivery of insulin shortly after an infusion set change. Over-delivery of insulin can cause hypoglycemia and in extreme cases, death. Medtronic has received reports of hypoglycemia requiring medical intervention potentially related to this issue. Are your MiniMed infusion sets part of the recall? We urge you […]

Dear Glu Community, We are deeply saddened by the aftermath of the recent hurricanes. We wanted to make sure that you know where to donate supplies or access them if you or a loved one are in need. Below, we have compiled a list of resources. To donate supplies: To donate insulin click here (Insulin for […]

Medicaid is a crucial source of coverage for patients and consumers with serious and chronic healthcare needs, including type 1 diabetes. But proposals to phase out Medicaid expansion and implement per capita caps or block grants, like those included in the American Health Care Act (AHCA), HR 1628, threaten the ability of Medicaid to provide […]

Dear Friends, 14,000 people just spent 5 days learning to be better researchers, clinicians, scientists, and innovators in diabetes This is my fifteenth consecutive year attending the American Diabetes Association’s Scientific Sessions (the largest diabetes event in the world) where more than 14,000 global leaders meet to learn, share, and experience cutting-edge research and technology, […]

In September, the FDA approved a big leap forward in diabetes technology, the world’s first hybrid closed loop system. The MiniMed® 670G system is designed for people with type 1 diabetes who are 14 and older.  Having been diagnosed with type 1 in 1989, when blood glucose meters were bigger than the current larger iPhone, […]